Clinical News
View All >>Mount Sinai Launches Institute for Airway Sciences
17 hours ago
By Armand Butera
The newest venture from Mount Sinai is intended to build a pipeline of physician-scientists.
Influenza Vaccination Rates Increasing for Asthmatic Children
19 hours ago
By Kenny Walter
More than 70% of parents of children with asthma said they in favor of the influenza vaccine during the COVID-19 pandemic.
Wouter Hoogenboom, PhD, Tim Duong, PhD: Examining COVID-19 Outcomes in SCD, SCT
January 14, 2022
By Giuliana Grossi
Investigators conducted an extensive literature review on clinical COVID-19 outcomes in patients with SCD or SCT to better navigate treatment during the pandemic.
FDA Approves Abrocitinib for Moderate to Severe Atopic Dermatitis in Adult Patients
January 14, 2022
By Armand Butera
The decision was supported by 5 clinical trials that resulted in significant improvements in skin clearance, extent of disease, and severity.
Regina Hartfield is Now the CEO and President of SCDAA
January 14, 2022
By Giuliana Grossi
Regina Hartfield is the new CEO and president of the Sickle Cell Association of America. Listen to our interview with her to find out what's in store for 2022.
Better Minority Enrollment Needed in UK Multiple Myeloma Trials
December 14, 2021
By Kenny Walter
The enrollment distribution was consistent by ethnicity over the course of 18 years, with no change in diversity over time despite there being an increase in the UK in the minority population.
Fuad El Rassi, MD, Tracks COVID-19 and Sickle Cell Disease For a Year
December 14, 2021
By Giuliana Grossi
Of the SCD patients who contracted COVID-19, 49% of them visited the Grady Comprehensive Sickle Cell center because of a vaso-occlusive event.
Identifying Distinct Cognitive Profiles Of Adults With SCD May Reduce Morbidity
December 14, 2021
By Connor Iapoce
Data show patients with sickle cell disease identified by distinct cognitive profile should have neurorehabilitation tailored to each unique profile.
Voxelotor May Improve Exercise Capacity In Patients With Sickle Cell Anemia
December 14, 2021
By Connor Iapoce
After 2 months of voxelotor treatment, all patients with sickle cell anemia perceived global improvement, but peak VO2 did not change in 8 of 9 patients.
January 14, 2022 7:31 PM
By Jeffrey Bratberg, PharmD, FAPhA, University of Rhode Island College of Pharmacy
January 14, 2022 6:55 PM
By Armand Butera
January 14, 2022 6:30 PM
By Giuliana Grossi
January 14, 2022 5:02 PM
By Edio Zampaglione, MD
January 14, 2022 5:00 PM
By Victoria Johnson
January 14, 2022 3:30 PM
By Giuliana Grossi
January 14, 2022 2:00 PM
By Giuliana Grossi
January 13, 2022 11:00 PM
By Connor Iapoce
January 13, 2022 8:30 PM
By Stephen B. Hanauer, MD, Northwestern University Feinberg School of Medicine
January 13, 2022 7:11 PM
By Kenny Walter
January 13, 2022 7:00 PM
By Armand Butera
January 13, 2022 5:00 PM
By Connor Iapoce
